2010
DOI: 10.1016/j.humimm.2010.02.003
|View full text |Cite
|
Sign up to set email alerts
|

Association analysis of MICA gene polymorphism and MICA-129 dimorphism with inflammatory bowel disease susceptibility in a Spanish population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
50
1

Year Published

2012
2012
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 50 publications
(53 citation statements)
references
References 26 publications
(35 reference statements)
2
50
1
Order By: Relevance
“…These clinical and autoimmune markers do vary in the different age categories, supporting the conclusion that MICA contributes to the disease irrespective of the autoimmune markers and residual ␤ cell function. These findings and interpretations were in line with other pathological contexts (3,9,14,23,25,29,34,41).…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…These clinical and autoimmune markers do vary in the different age categories, supporting the conclusion that MICA contributes to the disease irrespective of the autoimmune markers and residual ␤ cell function. These findings and interpretations were in line with other pathological contexts (3,9,14,23,25,29,34,41).…”
Section: Discussionsupporting
confidence: 90%
“…In addition, MICA alleles may also be associated with susceptibility or resistance to developing autoimmunity (10). Recently, several authors have shown that the MICA-129 polymorphism was associated with several pathologies (9,14,23). In contrast, it has been demonstrated that a change of methionine to valine at position 129 of the ␣2-heavy chain domain classifies MICA alleles into strong (MICA-129 Met) or weak (MICA-129 Val) binders of NKG2D receptor (33).…”
Section: Discussionmentioning
confidence: 99%
“…As the Th2 response is predominant in pathological UC mucosa [49], the protective role of MICA*A4 makes sense. L opez-Hern andez and colleagues [37] described the protective role of the MICA-129Met/Val heterozygous genotype, but there were only 29 UC patients in their study and these results must be interpreted with caution. MICA*A4 is also in strong LD, with the amino acid substitution of glycine (Gly) by tryptophan (Trp) at position 14 in the a1 domain, and this change may affect the affinity of MICA with the NKG2D receptor [50].…”
Section: Discussionmentioning
confidence: 90%
“…Certain MICA-STR alleles have been associated with immune-mediated diseases [12,[25][26][27][28][29][30], including IBD: some revealed an association of MICA*A6 [31,32] or MICA*A5.1 with UC [33,34], while these results could not be replicated in other cohorts [35][36][37]. Moreover, MICA-STR alleles have been associated with UC phenotype, as location of disease [32,38], age at onset [32,39] or extraintestinal manifestations (EIMs) [7,33,39].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation